Article 1
The Annex to Implementing Regulation (EU) 2015/408 is amended in accordance with the Annex to this Regulation.
Commission Implementing Regulation (EU) 2022/1252 of 19 July 2022 amending Implementing Regulation (EU) 2015/408 to update the list of candidates for substitution (Text with EEA relevance)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
The Annex to Implementing Regulation (EU) 2015/408 is amended in accordance with the Annex to this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX In the Annex to Implementing Regulation (EU) 2015/408 the following entries are deleted: amitrole; bifenthrin; bromadiolone; carbendazim; carbetamide; copper compounds (variants copper hydroxide, copper oxychloride, copper oxide, Bordeaux mixture and tribasic copper sulphate); cyproconazole; difenacoum; dimethoate; diquat; epoxiconazole; esfenvalerate; ethoprophos; etoxazole; famoxadone; fenamiphos; fenbutatin oxide; fipronil; fluquinconazole; glufosinate; haloxyfop-P; imazamox; imazosulfuron; isoproturon; isopyrazam; lambda-cyhalothrin; linuron; lufenuron; mecoprop; methomyl; metsulfuron-methyl; molinate; myclobutanil; oxadiargyl; oxadiazon; pendimethalin; prochloraz; profoxydim; propiconazole; prosulfuron; quinoxyfen; quizalofop-P (variant quizalofop-P-tefuryl); tepraloxydim; thiacloprid; triasulfuron; triazoxide; warfarin.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.